Home Newsfeeds Towne Bank Q2 EPS $0.64 Down From $0.77 YoY

Towne Bank Q2 EPS $0.64 Down From $0.77 YoY

Towne Bank (NASDAQ:TOWN) reported quarterly earnings of $0.64 per share. This is a 16.88 percent decrease over earnings of $0.77 per share from the same period last year.

byBill Haddad

July 28, 2022

1 minute read

Towne Bank (NASDAQ:TOWN) reported quarterly earnings of $0.64 per share. This is a 16.88 percent decrease over earnings of $0.77 per share from the same period last year.

News

U.S. FTC Orders End To ‘Illegal’ Mastercard Business Tactics And Requires It To Stop ‘Blocking Competing Debit Card Payment Networks”

By Benzinga Newsdesk

December 23, 12:08 PM

https://www.ftc.gov/news-events/news/press-releases/2022/12/ftc

News

KULR Technology Group Delivers Customized Battery Solution For U.S. Army, Enhancing Tactical Command Operations

By Benzinga Newsdesk

April 10, 8:36 AM

KULR Technology Group, Inc. (NYSE:KULR) (the "Company" or "KULR"), an innovator in energy management systems, proudly announces the successful delivery of its custom-designed KULR ONE battery packs to the United States

KULR

Elon Musk Reacts As Former GOP Presidential Candidate Warns Of ‘Another 9/11-Scale Tragedy’ Amid Rising Border Crisis: ‘Only A Matter Of Time’

By Benzinga Neuro

April 9, 6:38 AM

Musk quoted a post by Vivek Ramaswamy, former presidential candidate and entrepreneur, who expressed concern over the potential threat posed by illegal aliens crossing the southern border.

TSLA

Jaguar Health Announces Submission Of Orphan Drug Designation Application To The FDA For Crofelemer For Cholera-Related Diarrhea

By Benzinga Newsdesk

February 12, 9:35 AM

Cholera is an acute diarrheal illness caused by infection of the intestine with the bacterium Vibrio choleraeCrofelemer previously granted Orphan Drug Designation by the FDA and the EMA for both short bowel syndrome and

JAGX

Towne Bank Q2 EPS $0.64 Down From $0.77 YoY

Related Posts

U.S. FTC Orders End To ‘Illegal’ Mastercard Business Tactics And Requires It To Stop ‘Blocking Competing Debit Card Payment Networks”

KULR Technology Group Delivers Customized Battery Solution For U.S. Army, Enhancing Tactical Command Operations

Elon Musk Reacts As Former GOP Presidential Candidate Warns Of ‘Another 9/11-Scale Tragedy’ Amid Rising Border Crisis: ‘Only A Matter Of Time’

Jaguar Health Announces Submission Of Orphan Drug Designation Application To The FDA For Crofelemer For Cholera-Related Diarrhea